发明名称 SUBSTITUTED BENZIMIDAZOL-2-ONES AS VASOPRESSIN RECEPTOR ANTAGONISTS AND NEUROPEPTIDE Y MODULATORS
摘要 The invention is directed to substituted benzimidazol-2-ones of Formula (I), wherein A, X, Y, m, n, R1, R2, R3, R4, and R5 are as described in the specification, which are useful as vasopressin receptor antagonists or Neuropeptide Y Modulators for treating conditions such as aggression, obsessive-compulsive disorders, hypertension, dysmenorrhea, congestive heart failure/cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, edema, ischemia, stroke, thrombosis, water retention, nephrotic syndrome, central nervous injuries, obesity, anorexia, hyperglycemia, diabetes, anxiety, depression, asthma, memory loss, sexual dysfunction, disorders of sleep and other circadian rhythms, and Cushing's disease.
申请公布号 WO02055514(A3) 申请公布日期 2002.11.21
申请号 WO2001US51108 申请日期 2001.10.23
申请人 ORTHO-MCNEIL PHARMACEUTICAL, INC. 发明人 URBANSKI, MAUD, J.;GUNNET, JOSEPH, W., JR.;DEMAREST, KEITH, T.
分类号 A61K31/454;A61K31/4545;A61K31/496;A61K31/5377;A61P1/16;A61P3/00;A61P3/04;A61P3/10;A61P5/12;A61P9/10;A61P9/12;A61P11/00;A61P13/12;A61P15/00;A61P15/10;A61P25/00;A61P25/02;A61P25/20;A61P25/22;A61P25/24;A61P43/00;C07D401/04;C07D401/14;C07D405/14;C07D409/14;C07D417/14 主分类号 A61K31/454
代理机构 代理人
主权项
地址